Koshinski Asset Management Inc. cut its stake in Clorox Co (NYSE:CLX) by 29.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,299 shares of the company’s stock after selling 1,792 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Clorox were worth $943,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Coastal Capital Group Inc. acquired a new stake in shares of Clorox during the 1st quarter worth about $25,000. Simon Quick Advisors LLC increased its position in shares of Clorox by 1,522.2% during the 1st quarter. Simon Quick Advisors LLC now owns 146 shares of the company’s stock worth $25,000 after purchasing an additional 137 shares during the last quarter. Asset Dedication LLC acquired a new stake in shares of Clorox during the 1st quarter worth about $25,000. Evolution Wealth Advisors LLC increased its position in shares of Clorox by 581.8% during the 1st quarter. Evolution Wealth Advisors LLC now owns 150 shares of the company’s stock worth $26,000 after purchasing an additional 128 shares during the last quarter. Finally, Costello Asset Management INC acquired a new stake in shares of Clorox during the 2nd quarter worth about $27,000. 78.55% of the stock is owned by institutional investors and hedge funds.
A number of analysts recently issued reports on CLX shares. Barclays reissued a “sell” rating and set a $164.00 price objective on shares of Clorox in a research report on Tuesday, May 5th. JPMorgan Chase & Co. raised their price objective on Clorox from $203.00 to $235.00 and gave the stock an “overweight” rating in a research report on Thursday, July 16th. UBS Group raised their price objective on Clorox from $155.00 to $168.00 and gave the stock a “sell” rating in a research report on Monday, May 4th. Deutsche Bank lifted their target price on Clorox from $174.00 to $223.00 and gave the company a “hold” rating in a research report on Monday, July 27th. Finally, DA Davidson initiated coverage on Clorox in a research report on Monday, June 29th. They issued a “buy” rating for the company. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $185.08.
In related news, SVP Denise Garner sold 25,832 shares of the business’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $197.62, for a total transaction of $5,104,919.84. Following the completion of the sale, the senior vice president now owns 17,468 shares in the company, valued at $3,452,026.16. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Jeff Baker sold 5,158 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $203.74, for a total value of $1,050,890.92. Following the sale, the chief accounting officer now owns 7,963 shares of the company’s stock, valued at approximately $1,622,381.62. The disclosure for this sale can be found here. Insiders sold a total of 73,011 shares of company stock valued at $14,788,606 in the last quarter. Company insiders own 1.14% of the company’s stock.
Shares of CLX opened at $236.51 on Friday. The stock has a 50-day simple moving average of $221.18 and a 200-day simple moving average of $190.13. The company has a debt-to-equity ratio of 3.69, a quick ratio of 0.72 and a current ratio of 0.98. The stock has a market capitalization of $29.78 billion, a PE ratio of 34.68, a PEG ratio of 5.30 and a beta of 0.27. Clorox Co has a 1 year low of $144.12 and a 1 year high of $238.00.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Friday, May 1st. The company reported $1.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.17. The business had revenue of $1.78 billion during the quarter, compared to analysts’ expectations of $1.69 billion. Clorox had a return on equity of 147.52% and a net margin of 13.67%. The business’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.44 EPS. Analysts predict that Clorox Co will post 6.92 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Wednesday, July 29th will be paid a $1.11 dividend. This represents a $4.44 annualized dividend and a dividend yield of 1.88%. The ex-dividend date is Tuesday, July 28th. This is a boost from Clorox’s previous quarterly dividend of $1.06. Clorox’s dividend payout ratio (DPR) is presently 70.25%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: What is Green Investing?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.